Sickle cell anemia (SCA) is a life‐threatening genetic condition contributing to high‐risk
pregnancies affecting both the mother and fetus. With improved management of children …

This review provides an overview of reproductive and sexual healthcare concerns for
individuals with SCD and their families. Reproductive and sexual health care are …

Adverse pregnancy outcomes occur frequently in women with sickle cell disease (SCD)
across the globe. In the United States, Black women experience disproportionately worse …

Given the low risk classification, lack of alternative therapies, dismal, stagnant pregnancy
outcomes and the potential for profound treatment benefit, wider use of chronic transfusion …

Growing recognition that the ovary is an end organ in sickle cell disease (SCD), advances in
SCD treatment and cure, and innovations in assisted reproductive technologies invite …

Introduction Sickle cell disease (SCD), its treatments and cures present infertility risks.
Fertility counseling is broadly indicated for affected girls and women and fertility preservation …

Pregnancy in women with sickle cell disease (SCD) is a life-threatening condition. In both
high-and low-income countries, there is an 11-fold increased risk of maternal death and a 4 …

Pregnancy in women with sickle cell disease (SCD) is fraught with complications, some of
which are life-threatening. Managing pregnancy in these women can be challenging …

Background Sickle cell disease (SCD) has evolved from a condition predominantly fatal in
childhood to a chronic illness impacting many adults, including women of reproductive age …

Background: Sickle cell disease (SCD) has evolved from a condition predominantly fatal in
childhood to a chronic illness impacting many adults, including women of reproductive age …